Female sex is linked to a stronger association between sTREM2 and CSF p-tau in Alzheimer's disease
- PMID: 39794447
- PMCID: PMC11822105
- DOI: 10.1038/s44321-024-00190-3
Female sex is linked to a stronger association between sTREM2 and CSF p-tau in Alzheimer's disease
Abstract
In Alzheimer's disease (AD), Aβ triggers p-tau secretion, which drives tau aggregation. Therefore, it is critical to characterize modulators of Aβ-related p-tau increases which may alter AD trajectories. Here, we assessed whether factors known to alter tau levels in AD modulate the association between fibrillar Aβ and secreted p-tau181 determined in the cerebrospinal fluid (CSF). To assess potentially modulating effects of female sex, younger age, and ApoE4, we included 322 ADNI participants with cross-sectional/longitudinal p-tau181. To determine effects of microglial activation on p-tau181, we included 454 subjects with cross-sectional CSF sTREM2. Running ANCOVAs for nominal and linear regressions for metric variables, we found that women had higher Aβ-related p-tau181 levels. Higher sTREM2 was associated with elevated p-tau181, with stronger associations in women. Similarly, ApoE4 was related to higher p-tau181 levels and faster p-tau181 increases, with stronger effects in female ApoE4 carriers. Our results show that sex alone modulates the Aβ to p-tau axis, where women show higher Aβ-dependent p-tau secretion, potentially driven by elevated sTREM2-related microglial activation and stronger effects of ApoE4 carriership in women.
Keywords: Alzheimer’s Disease; Microglia; Sex Differences; p-tau; sTREM2.
© 2025. The Author(s).
Conflict of interest statement
Disclosure and competing interests statement. The authors declare no competing interests.
Figures



References
-
- Alzheimer’s A (2014) 2014 Alzheimer’s disease facts and figures. Alzheimers Dement 10:e47–92 - PubMed
-
- Asaro A, Carlo-Spiewok AS, Malik AR, Rothe M, Schipke CG, Peters O, Heeren J, Willnow TE (2020) Apolipoprotein E4 disrupts the neuroprotective action of sortilin in neuronal lipid metabolism and endocannabinoid signaling. Alzheimers Dement 16:1248–1258 - PubMed
-
- Babapour Mofrad R, Tijms BM, Scheltens P, Barkhof F, van der Flier WM, Sikkes SAM, Teunissen CE (2020) Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE epsilon4 genotype. Neurology 95:e2378–e2388 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources